Logo image of JRSH

JERASH HOLDINGS US INC (JRSH) Stock Fundamental Analysis

USA - NASDAQ:JRSH - US47632P1012 - Common Stock

3.26 USD
+0.01 (+0.31%)
Last: 10/17/2025, 8:24:10 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to JRSH. JRSH was compared to 48 industry peers in the Textiles, Apparel & Luxury Goods industry. The financial health of JRSH is average, but there are quite some concerns on its profitability. JRSH has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

JRSH had positive earnings in the past year.
In the past year JRSH has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: JRSH reported negative net income in multiple years.
JRSH had a positive operating cash flow in 4 of the past 5 years.
JRSH Yearly Net Income VS EBIT VS OCF VS FCFJRSH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.00%, JRSH is doing worse than 66.67% of the companies in the same industry.
With a Return On Equity value of 1.30%, JRSH is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
JRSH has a Return On Invested Capital of 3.77%. This is in the lower half of the industry: JRSH underperforms 72.92% of its industry peers.
Industry RankSector Rank
ROA 1%
ROE 1.3%
ROIC 3.77%
ROA(3y)-0.22%
ROA(5y)2.84%
ROE(3y)-0.32%
ROE(5y)3.54%
ROIC(3y)N/A
ROIC(5y)N/A
JRSH Yearly ROA, ROE, ROICJRSH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1.3 Margins

With a Profit Margin value of 0.56%, JRSH is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Looking at the Operating Margin, with a value of 2.24%, JRSH is doing worse than 72.92% of the companies in the same industry.
In the last couple of years the Operating Margin of JRSH has declined.
JRSH's Gross Margin of 16.45% is on the low side compared to the rest of the industry. JRSH is outperformed by 87.50% of its industry peers.
In the last couple of years the Gross Margin of JRSH has declined.
Industry RankSector Rank
OM 2.24%
PM (TTM) 0.56%
GM 16.45%
OM growth 3Y-48.63%
OM growth 5Y-34.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.01%
GM growth 5Y-4.58%
JRSH Yearly Profit, Operating, Gross MarginsJRSH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20 25

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so JRSH is destroying value.
The number of shares outstanding for JRSH has been increased compared to 1 year ago.
JRSH has more shares outstanding than it did 5 years ago.
JRSH has a worse debt/assets ratio than last year.
JRSH Yearly Shares OutstandingJRSH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
JRSH Yearly Total Debt VS Total AssetsJRSH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 4.37 indicates that JRSH is not in any danger for bankruptcy at the moment.
JRSH has a Altman-Z score of 4.37. This is in the better half of the industry: JRSH outperforms 77.08% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that JRSH is not too dependend on debt financing.
The Debt to Equity ratio of JRSH (0.08) is better than 79.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 4.37
ROIC/WACC0.29
WACC12.98%
JRSH Yearly LT Debt VS Equity VS FCFJRSH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

JRSH has a Current Ratio of 2.85. This indicates that JRSH is financially healthy and has no problem in meeting its short term obligations.
JRSH's Current ratio of 2.85 is amongst the best of the industry. JRSH outperforms 85.42% of its industry peers.
A Quick Ratio of 1.39 indicates that JRSH should not have too much problems paying its short term obligations.
JRSH has a better Quick ratio (1.39) than 72.92% of its industry peers.
Industry RankSector Rank
Current Ratio 2.85
Quick Ratio 1.39
JRSH Yearly Current Assets VS Current LiabilitesJRSH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

6

3. Growth

3.1 Past

JRSH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 122.58%, which is quite impressive.
The Revenue has grown by 17.11% in the past year. This is quite good.
Measured over the past years, JRSH shows a quite strong growth in Revenue. The Revenue has been growing by 9.41% on average per year.
EPS 1Y (TTM)122.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%127.27%
Revenue 1Y (TTM)17.11%
Revenue growth 3Y0.56%
Revenue growth 5Y9.41%
Sales Q2Q%-3.19%

3.2 Future

Based on estimates for the next years, JRSH will show a very strong growth in Earnings Per Share. The EPS will grow by 65.70% on average per year.
The Revenue is expected to grow by 8.47% on average over the next years. This is quite good.
EPS Next Y442.43%
EPS Next 2Y170.53%
EPS Next 3Y117.62%
EPS Next 5Y65.7%
Revenue Next Year3.09%
Revenue Next 2Y5.69%
Revenue Next 3Y7.46%
Revenue Next 5Y8.47%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
JRSH Yearly Revenue VS EstimatesJRSH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
JRSH Yearly EPS VS EstimatesJRSH Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 0.4 0.6

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 46.57, the valuation of JRSH can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of JRSH indicates a slightly more expensive valuation: JRSH is more expensive than 66.67% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of JRSH to the average of the S&P500 Index (27.40), we can say JRSH is valued expensively.
The Price/Forward Earnings ratio is 8.76, which indicates a very decent valuation of JRSH.
JRSH's Price/Forward Earnings ratio is rather cheap when compared to the industry. JRSH is cheaper than 93.75% of the companies in the same industry.
JRSH is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 46.57
Fwd PE 8.76
JRSH Price Earnings VS Forward Price EarningsJRSH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JRSH indicates a somewhat cheap valuation: JRSH is cheaper than 79.17% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.04
JRSH Per share dataJRSH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
JRSH's earnings are expected to grow with 117.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.11
PEG (5Y)N/A
EPS Next 2Y170.53%
EPS Next 3Y117.62%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.15%, JRSH is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.29, JRSH pays a better dividend. On top of this JRSH pays more dividend than 93.75% of the companies listed in the same industry.
JRSH's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 6.15%

5.2 History

The dividend of JRSH decreases each year by -1.64%.
JRSH has been paying a dividend for over 5 years, so it has already some track record.
JRSH has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-1.64%
Div Incr Years0
Div Non Decr Years6
JRSH Yearly Dividends per shareJRSH Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

303.98% of the earnings are spent on dividend by JRSH. This is not a sustainable payout ratio.
DP303.98%
EPS Next 2Y170.53%
EPS Next 3Y117.62%
JRSH Yearly Income VS Free CF VS DividendJRSH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M 6M 8M 10M
JRSH Dividend Payout.JRSH Dividend Payout, showing the Payout Ratio.JRSH Dividend Payout.PayoutRetained Earnings

JERASH HOLDINGS US INC

NASDAQ:JRSH (10/17/2025, 8:24:10 PM)

3.26

+0.01 (+0.31%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners7.37%
Inst Owner Change0.02%
Ins Owners22.48%
Ins Owner Change0%
Market Cap41.40M
Analysts82.5
Price Target4.59 (40.8%)
Short Float %0.13%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield 6.15%
Yearly Dividend0.2
Dividend Growth(5Y)-1.64%
DP303.98%
Div Incr Years0
Div Non Decr Years6
Ex-Date08-22 2025-08-22 (0.05)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-100%
Min EPS beat(2)-198.04%
Max EPS beat(2)-1.96%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.09%
Min Revenue beat(2)-12.3%
Max Revenue beat(2)-1.89%
Revenue beat(4)1
Avg Revenue beat(4)-4.18%
Min Revenue beat(4)-12.3%
Max Revenue beat(4)5.34%
Revenue beat(8)2
Avg Revenue beat(8)-6.79%
Revenue beat(12)4
Avg Revenue beat(12)-3.93%
Revenue beat(16)6
Avg Revenue beat(16)-2.27%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.96%
Valuation
Industry RankSector Rank
PE 46.57
Fwd PE 8.76
P/S 0.29
P/FCF N/A
P/OCF N/A
P/B 0.66
P/tB 0.67
EV/EBITDA 6.04
EPS(TTM)0.07
EY2.15%
EPS(NY)0.37
Fwd EY11.42%
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS11.38
BVpS4.94
TBVpS4.9
PEG (NY)0.11
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1%
ROE 1.3%
ROCE 5.14%
ROIC 3.77%
ROICexc 4.12%
ROICexgc 4.16%
OM 2.24%
PM (TTM) 0.56%
GM 16.45%
FCFM N/A
ROA(3y)-0.22%
ROA(5y)2.84%
ROE(3y)-0.32%
ROE(5y)3.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-62.98%
ROICexcg growth 5Y-36.11%
ROICexc growth 3Y-62.79%
ROICexc growth 5Y-36.22%
OM growth 3Y-48.63%
OM growth 5Y-34.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.01%
GM growth 5Y-4.58%
F-Score5
Asset Turnover1.77
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA 0.81
Cap/Depr 48.29%
Cap/Sales 0.89%
Interest Coverage 2.03
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.85
Quick Ratio 1.39
Altman-Z 4.37
F-Score5
WACC12.98%
ROIC/WACC0.29
Cap/Depr(3y)37.99%
Cap/Depr(5y)61.32%
Cap/Sales(3y)0.74%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)122.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%127.27%
EPS Next Y442.43%
EPS Next 2Y170.53%
EPS Next 3Y117.62%
EPS Next 5Y65.7%
Revenue 1Y (TTM)17.11%
Revenue growth 3Y0.56%
Revenue growth 5Y9.41%
Sales Q2Q%-3.19%
Revenue Next Year3.09%
Revenue Next 2Y5.69%
Revenue Next 3Y7.46%
Revenue Next 5Y8.47%
EBIT growth 1Y225.2%
EBIT growth 3Y-48.35%
EBIT growth 5Y-28.42%
EBIT Next Year565.39%
EBIT Next 3Y124.96%
EBIT Next 5Y69.89%
FCF growth 1Y-139.35%
FCF growth 3Y-59%
FCF growth 5Y-28.61%
OCF growth 1Y-125.78%
OCF growth 3Y-46.6%
OCF growth 5Y-27.71%